Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey

被引:2
作者
Burstein, Barry [1 ]
Altobelli, Kathleen K. [2 ]
Williams, Ken [2 ]
Cannon, Christopher P. [3 ]
Pencina, Michael J. [4 ]
Sniderman, Allan D. [5 ,6 ]
Thanassoulis, George [5 ,6 ]
机构
[1] McGill Univ, Montreal, PQ, Canada
[2] KenAnCo Biostat, San Antonio, TX USA
[3] Baim Inst Clin Res, Boston, MA USA
[4] Duke Clin Res Inst, Durham, NC USA
[5] McGill Univ, Ctr Hlth, Prevent & Genom Cardiol, Dept Med, Montreal, PQ, Canada
[6] Res Inst, Montreal, PQ, Canada
关键词
cardiovascular diseases; hydroxymethylglutaryl-CoA reductase inhibitors; primary prevention; risk; waist-hip ratio; RISK;
D O I
10.1161/CIRCULATIONAHA.117.029102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1860 / 1862
页数:3
相关论文
共 4 条
[1]   Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? [J].
Stern, MP ;
Williams, K ;
González-Villalpando, C ;
Hunt, KJ ;
Haffner, SM .
DIABETES CARE, 2004, 27 (11) :2676-2681
[2]   2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [J].
Stone, Neil J. ;
Robinson, Jennifer G. ;
Lichtenstein, Alice H. ;
Merz, C. Noel Bairey ;
Blum, Conrad B. ;
Eckel, Robert H. ;
Goldberg, Anne C. ;
Gordon, David ;
Levy, Daniel ;
Lloyd-Jones, Donald M. ;
McBride, Patrick ;
Schwartz, J. Sanford ;
Shero, Susan T. ;
Smith, Sidney C., Jr. ;
Watson, Karol ;
Wilson, Peter W. F. .
CIRCULATION, 2014, 129 (25) :S1-S45
[3]   Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease [J].
Thanassoulis, George ;
Williams, Ken ;
Altobelli, Kathleen Kimler ;
Pencina, Michael J. ;
Cannon, Christopher P. ;
Sniderman, Allan D. .
CIRCULATION, 2016, 133 (16) :1574-+
[4]   Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease [J].
Yusuf, S. ;
Bosch, J. ;
Dagenais, G. ;
Zhu, J. ;
Xavier, D. ;
Liu, L. ;
Pais, P. ;
Lopez-Jaramillo, P. ;
Leiter, L. A. ;
Dans, A. ;
Avezum, A. ;
Piegas, L. S. ;
Parkhomenko, A. ;
Keltai, K. ;
Keltai, M. ;
Sliwa, K. ;
Peters, R. J. G. ;
Held, C. ;
Chazova, I. ;
Yusoff, K. ;
Lewis, B. S. ;
Jansky, P. ;
Khunti, K. ;
Toff, W. D. ;
Reid, C. M. ;
Varigos, J. ;
Sanchez-Vallejo, G. ;
McKelvie, R. ;
Pogue, J. ;
Jung, H. ;
Gao, P. ;
Diaz, R. ;
Lonn, E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (21) :2021-2031